Drawing for FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT

USPTO serial 97467771

FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT

Reviewed by CopyMark Law Group

Reg. 7288670Status 700Registered
Filing date
Status date
Registration date
Jan 23, 2024
Examiner
MCDOWELL, MATTHEW J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph E. Washington

Joseph E. Washington MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
035Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportunities for underserved and needy communities by means of public advocacy and business administration of the patient assistance programs of others by enrolling patients in the assistance programs to assist them in saving money on their prescription medications; business administration of patient pharmaceutical reimbursement programs; business administration of a patient support and assistance program for obtaining reimbursement for prescription medicinesACTIVE—
044Providing medical information and educational information in the field of medicine about the treatment and prevention of ototoxicity from cisplatin in pediatric patientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 16, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 15, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 26, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 26, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 13, 2023IUAFUSE AMENDMENT FILED—
Nov 13, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 22, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 27, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 27, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2023DOCKASSIGNED TO EXAMINER—
Jul 9, 2022MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance